151 related articles for article (PubMed ID: 37268820)
1. mRNA vaccine for treating pancreatic cancer.
Bird L
Nat Rev Immunol; 2023 Jul; 23(7):413. PubMed ID: 37268820
[No Abstract] [Full Text] [Related]
2. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay].
Chuluyan E; Davio C; Dusetti N; Fraunhoffer N; Garcia MN; Garona J; González B; Gottardo F; Grasso D; Iovanna J; Kohan G; Lada PE; Mazza O; Monte M; Papademetrio D; Pasqualini ME; Sahores A; Santofimia P; Yaneff A
Medicina (B Aires); 2023; 83(4):650-652. PubMed ID: 37582144
[No Abstract] [Full Text] [Related]
3. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine.
Huang X; Zhang G; Tang TY; Gao X; Liang TB
Mil Med Res; 2022 Oct; 9(1):53. PubMed ID: 36224645
[TBL] [Abstract][Full Text] [Related]
4. [New strategy for treatment of patients with pancreatic cancer--clinical significance of peptide vaccine for pancreatic cancer].
Yamaue H
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1639-45. PubMed ID: 21971138
[No Abstract] [Full Text] [Related]
5. [Present and future status of therapeutic cancer peptide vaccine therapy for patients with pancreatic cancer].
Katsuda M; Yamaue H
Nihon Rinsho; 2015 Mar; 73 Suppl 3():433-7. PubMed ID: 25857063
[No Abstract] [Full Text] [Related]
6. [Current topics and future to vaccine for pancreatic cancer].
Miyazawa M; Yamaue H
Nihon Jibiinkoka Gakkai Kaiho; 2013 May; 116(5):573-80. PubMed ID: 24024272
[No Abstract] [Full Text] [Related]
7. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
Jaffee EM; Abrams R; Cameron J; Donehower R; Duerr M; Gossett J; Greten TF; Grochow L; Hruban R; Kern S; Lillemoe KD; O'Reilly S; Pardoll D; Pitt HA; Sauter P; Weber C; Yeo C
Hum Gene Ther; 1998 Sep; 9(13):1951-71. PubMed ID: 9741433
[No Abstract] [Full Text] [Related]
8. Mutated Ras peptides as vaccines in immunotherapy of cancer.
Gjertsen MK; Gaudernack G
Vox Sang; 1998; 74 Suppl 2():489-95. PubMed ID: 9704487
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers.
Toubaji A; Achtar M; Provenzano M; Herrin VE; Behrens R; Hamilton M; Bernstein S; Venzon D; Gause B; Marincola F; Khleif SN
Cancer Immunol Immunother; 2008 Sep; 57(9):1413-20. PubMed ID: 18297281
[TBL] [Abstract][Full Text] [Related]
10. A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment.
Chen Z; Zhang S; Han N; Jiang J; Xu Y; Ma D; Lu L; Guo X; Qiu M; Huang Q; Wang H; Mo F; Chen S; Yang L
Front Immunol; 2021; 12():691605. PubMed ID: 34484187
[TBL] [Abstract][Full Text] [Related]
11. Advances in therapeutic vaccines for pancreatic cancer.
Plate JM
Discov Med; 2012 Aug; 14(75):89-94. PubMed ID: 22935205
[TBL] [Abstract][Full Text] [Related]
12. Novel pancreatic cancer vaccines could unleash the army within.
Springett GM
Cancer Control; 2014 Jul; 21(3):242-6. PubMed ID: 24955709
[TBL] [Abstract][Full Text] [Related]
13. The latest in pancreatic cancer research: Lustgarten Foundation awardees present their findings.
Wilentz RE
Int J Pancreatol; 2001; 29(2):123-5. PubMed ID: 11876250
[No Abstract] [Full Text] [Related]
14. Immunotherapy for pancreatic cancer: current concepts.
Kaufman HL; Di Vito J; Hörig H
Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825
[TBL] [Abstract][Full Text] [Related]
15. Is the induction of tumor cell senescence the key to a good irradiated tumor vaccine?
Brown MP
Mol Ther; 2012 May; 20(5):884-6. PubMed ID: 22549805
[No Abstract] [Full Text] [Related]
16. Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Mizuguchi T; Torigoe T; Satomi F; Shima H; Kutomi G; Ota S; Ishii M; Hayashi H; Asakura S; Hirohashi Y; Meguro M; Kimura Y; Nishidate T; Okita K; Ishino M; Miyamoto A; Hatakenaka M; Sato N; Hirata K
Surg Today; 2016 Feb; 46(2):139-48. PubMed ID: 25649538
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies.
Yang J; Shangguan J; Eresen A; Li Y; Wang J; Zhang Z
Pathol Res Pract; 2019 Dec; 215(12):152691. PubMed ID: 31676092
[TBL] [Abstract][Full Text] [Related]
18. Active-specific immunotherapy of pancreatic carcinoma: usefulness of human pancreatic carcinomas in preparing autologous tumor vaccines.
Grossmann A; Rameken M; Klapdor R
Anticancer Res; 1997; 17(4B):3117-9. PubMed ID: 9329615
[TBL] [Abstract][Full Text] [Related]
19. Prospects for vaccine therapy for pancreatic cancer.
Gaudernack G
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):299-314. PubMed ID: 16549329
[TBL] [Abstract][Full Text] [Related]
20. [Adoptive immunotherapy for pancreatic cancer, using MUC1 specific CTL].
Masaki Y; Oka M
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1679-80. PubMed ID: 8886044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
